U.S. Healthy high growth potential

Zevra Therapeutics

Market Cap: US$633.2m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Axsome Therapeutics

Market Cap: US$5.1b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

TG Therapeutics

Market Cap: US$5.4b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$42.4b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Credo Technology Group Holding

Market Cap: US$16.0b

Provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.

Circle Internet Group

Market Cap: US$45.1b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Alkami Technology

Market Cap: US$2.9b

Provides cloud-based digital banking solutions in the United States.

Atour Lifestyle Holdings

Market Cap: US$5.0b

Through its subsidiaries, develops lifestyle brands around hotel offerings in the People’s Republic of China.

Nu Holdings

Market Cap: US$61.7b

Provides digital banking platform in Brazil, Mexico, Colombia, the Cayman Islands, and the United States.

FTC Solar

Market Cap: US$65.3m

Engages in the manufacture and service of solar tracker systems in the United States, Asia, Europe, the Middle East, North Africa, South Africa, and Australia.

Astera Labs

Market Cap: US$19.3b

Designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.

Super Micro Computer

Market Cap: US$29.8b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Ardelyx

Market Cap: US$1.1b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARMOUR Residential REIT

Market Cap: US$1.4b

Invests in residential mortgage-backed securities (MBS) in the United States.

Palomar Holdings

Market Cap: US$3.7b

A specialty insurance company, provides property and casualty insurance to individuals and businesses in the United States.

Niu Technologies

Market Cap: US$296.3m

Designs, manufactures, and sells electric scooters in the People's Republic of China, Europe, and internationally.

Mereo BioPharma Group

Market Cap: US$279.8m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Solaris Energy Infrastructure

Market Cap: US$1.9b

Provides mobile and scalable equipment-based solutions for use in distributed power generation and management of raw materials used in the completion of oil and natural gas wells in the United States.

DLocal

Market Cap: US$3.1b

Operates a payment processing platform worldwide.

Enovix

Market Cap: US$3.3b

Designs, develops, and manufactures lithium-ion battery cells in the United States and internationally.

Palantir Technologies

Market Cap: US$364.9b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

AST SpaceMobile

Market Cap: US$19.3b

Designs and develops the constellation of BlueBird satellites in the United States.

Legend Biotech

Market Cap: US$8.2b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Abeona Therapeutics

Market Cap: US$333.5m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Achieve Life Sciences

Market Cap: US$131.7m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Tenaya Therapeutics

Market Cap: US$138.4m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Delcath Systems

Market Cap: US$375.9m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

ARS Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Herc Holdings

Market Cap: US$3.8b

Operates as an equipment rental supplier in the United States and internationally.

German American Bancorp

Market Cap: US$1.5b

Operates as a financial holding company for German American Bank that provides retail and commercial banking, and health management services.

OS Therapies

Market Cap: US$54.0m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Ares Management

Market Cap: US$58.2b

Operates as an alternative asset manager in the United States, Europe, and Asia.

Remitly Global

Market Cap: US$3.5b

Engages in the provision of digital financial services in the United States, Canada, and internationally.

Myomo

Market Cap: US$75.9m

A wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally.

Soleno Therapeutics

Market Cap: US$4.5b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Capricor Therapeutics

Market Cap: US$298.0m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.